Indonesia Vaccines Market to 2032
Overview
The Indonesia Vaccines Market is expected to reach a 550.22 USD Billion by 2032 and is projected to grow at a CAGR of 11.60% from 2025 to 2032.
Revenue, 2024 (USD Billion)
301.98
Forecast, 2032 (USD Billion)
550.22
CAGR, 2024 - 2032
11.60%
Report Coverage
Indonesia
Indonesia Vaccines Market 2018-2032 USD Billion
Indonesia Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 301.98 USD Billion
- Projected Market Size (2032): 550.22 USD Billion
- CAGR (2025-2032): 11.60%
Key Findings of Indonesia Vaccines Market
- The Indonesia Vaccines Market was valued at 301.98 USD Billion in 2024.
- The Indonesia Vaccines Market is likely to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 276.08 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 13.64% during the forecast period from 2024 to 2032.
Indonesia Vaccines Market Scope
Indonesia Vaccines Market Segmentation & Scope
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Composition
- Mono Vaccines
- Combination Vaccines
Indonesia Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 301.98 USD Billion |
| Market Value in 2032 | 550.22 USD Billion |
| CAGR (2025-2032) | 11.60% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Age of Administration,Diseases,Route of Administration,Kind,Type,End User,Distribution Channel,Composition |
Regional Insights:
-
Leading Market (2024-2032): Indonesia, leading in terms of revenue 301.98 USD Billion in 2024
- Key Country: Indonesia, leading in terms of revenue with value of 301.98 USD Billion in 2024.
Segments and Scope
-
Indonesia Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 193.08 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 11.40 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 44.08 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 12.65 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 276.08 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 11.64 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 213.43 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 11.18 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 105.58 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 12.49 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 209.40 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 11.38 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 230.80 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 11.26 % in forecast period 2025-2032.
-
Indonesia Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in Indonesia Vaccines Market to 2032 with a revenue of 236.01 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Indonesia Vaccines Market to 2032 with a Growth rate of 11.87 % in forecast period 2025-2032.
Indonesia Vaccines Market Company Share Analysis
Indonesia Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
Indonesia Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Indonesia Vaccines Market is segmented based on Segmentation Age of Administration,Diseases,Route of Administration,Kind,Type,End User,Distribution Channel,Composition.
Indonesia Vaccines Market was valued at USD 301.98(Revenue in USD Billion) in 2020.
Indonesia Vaccines Market is projected to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Indonesia Vaccines Market, holding a largest market share of 276.08 USD Billion in 2024
Coming Soon....
Indonesia Vaccines Market Scope
Indonesia Vaccines Market Segmentation & Scope
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Composition
- Mono Vaccines
- Combination Vaccines
Frequently Asked Questions
The Indonesia Vaccines Market is segmented based on Segmentation Age of Administration,Diseases,Route of Administration,Kind,Type,End User,Distribution Channel,Composition.
Indonesia Vaccines Market was valued at USD 301.98(Revenue in USD Billion) in 2020.
Indonesia Vaccines Market is projected to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Vaccines Market for final year is USD 550.22 (USD Billion).
Indonesia Vaccines Market Company Profiling
Frequently Asked Questions
The Indonesia Vaccines Market is segmented based on Segmentation Age of Administration,Diseases,Route of Administration,Kind,Type,End User,Distribution Channel,Composition.
Indonesia Vaccines Market was valued at USD 301.98(Revenue in USD Billion) in 2020.
Indonesia Vaccines Market is projected to grow at a CAGR of 11.60% during the forecast period of 2024 to 2032.
The estimated market value of the Indonesia Vaccines Market for final year is USD 550.22 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.